NWBO (NWBO) Stock Price & Analysis
NWBO (NWBO) rose 0.00% to USD 0.17 as of September 9, 2026 at 06:06 UTC, according to Nexqual real-time market data.
NWBO last closed at USD 0.17; the session ranged USD 0.17–0.17 on volume of 1,079,527 shares. Market capitalization is —, with a 52-week range of USD 0.14–0.34 (OQB). Source: Nexqual, September 9, 2026 at 06:06 UTC.
Key Statistics (as of September 9, 2026 at 06:06 UTC)
| Price | USD 0.17 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.17 |
| Open | USD 0.17 |
| Day Range | USD 0.17 – 0.17 |
| 52-Week Range | USD 0.14 – 0.34 |
| Volume | 1,079,527 shares |
| Market Cap | — |
| Exchange | OQB |
Technical Analysis (NWBO)
Nexqual's technical model rates NWBO "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 06:06 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.91 (neutral) |
| vs SMA50 | Below (USD 0.18) |
| MACD | -0 (negative) |
From NWBO's Latest SEC 10-K Filing (filed 2026-04-15)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IMUC | EOM Pharmaceutical Holdings Inc | USD 0.2 | ▲ 32.45% |
| CLDX | Celldex Therapeutics, Inc. | USD 39.12 | ▼ 0.64% |
| CVM | Cel-Sci Corporation | USD 1.65 | ▲ 2.48% |
| ATNM | Actinium Pharmaceuticals, Inc. | USD 1.23 | ▲ 17.14% |
| AGEN | Agenus Inc. | USD 7.43 | ▼ 9.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 06:06 UTC. This page is informational and not investment advice.